A New Era in Personalised Cancer Care

Advanced technology that understands your cancer, giving you the best chance of recovery and survival

Personalise your cancer treatment journey

Tempus’ advanced genomic testing

Superior Clinical Utility

Advancing genetics-driven cancer treatment opportunities

Tailored treatment

ENLIGHT analyses your cancer’s genetic makeup to ensure you receive the most effective treatment, reducing trial and error.

Enhanced treatment outcomes

Our advanced AI technology helps doctors choose therapies that offer the best chance of success, improving survival and reducing side effects.

Identify

Therapies you may not have already considered

Personalise your cancer treatment journey

Advancing genetics-driven cancer treatment opportunities

Tailored treatment

ENLIGHT analyses your cancer’s genetic makeup to ensure you receive the most effective treatment, reducing trial and error.

Enhanced treatment outcomes

Our advanced AI technology helps doctors choose therapies that offer the best chance of success, improving survival and reducing side effects.

Identify

Therapies you may not have already considered

ENLIGHT│Treatment designed for your needs

Advancing genetics-driven cancer treatment opportunities
We understand that every cancer journey is personal. With ENLIGHT, you can be confident that your treatment is designed with your unique needs in mind.

Frequently asked questions

ENLIGHT is a platform that helps doctors personalise cancer treatment by combining your tumour’s genetic makeup with information from various cancer therapies to identify the most effective treatments.
By predicting which treatments will work best for your specific tumour, ENLIGHT increases the chances of treatment success and reduces unnecessary side effects.
ENLIGHT has been tested across multiple cancer types, including difficult-to-treat cancers like triple-negative breast cancer, uveal melanoma, and non-small cell lung cancer.
ENLIGHT has shown an 80% success rate in predicting responses to treatments in clinical trials across several cancer types.
ENLIGHT uses AI and transcriptomics to analyse your tumour at a deeper genetic level, allowing your doctor to choose therapies tailored to your biology rather than a one-size-fits-all approach.
Yes, ENLIGHT has been validated in numerous studies, including retrospective analyses and clinical trials, demonstrating improved patient outcomes even in cases where traditional methods fail.
ENLIGHT can still help. It identifies treatment options even for patients who did not find gene mutations in the genetic test
While no treatment can guarantee success, ENLIGHT greatly increases the likelihood of identifying the most effective therapy for you, improving your chances of a better outcome.
Your doctor will provide a sample of your tumour sequencing data and/or histopathology data, which will be analysed using ENLIGHT’s Advanced-AI platform to determine which treatments are most likely to be effective.
ENLIGHT is effective in predicting the most effective treatments, even for patients who did not respond to conventional therapies, but there is a risk that no effective treatments are identified
Coverage depends on your PMI and level of coverage you’ve opted into. Your oncologist can help guide you through the process.
Not necessarily. ENLIGHT’s analysis is based on your existing tumour samples; however, your doctor might request a biopsy if the data from your existing tumour samples is not sufficient.
Results typically take less than a week, depending on the availability of the tumour sample data.
Speak to your oncologist about ENLIGHT and how it can help guide your treatment. They can help you determine if it’s the right option and order the test accordingly.
ENLIGHT complements your doctor’s expertise, providing additional insights to fine-tune or adjust your treatment plan for the best possible outcome.

Choose ENLIGHT, get genetics-driven treatment

Connect with us to discover the possibilities
Contact us to learn more about how ENLIGHT can help you turn the power of your genes into personalised treatment solutions.

Connect with us

UK office

South Africa office
Website's carbon footprint
We are committed to responsible business practices, championing SDGs in every facet of our work to achieve net-zero targets.